ES2051643A1 - Oral ubidecarenone formulations in the form of aqueous solutions - Google Patents

Oral ubidecarenone formulations in the form of aqueous solutions

Info

Publication number
ES2051643A1
ES2051643A1 ES09202032A ES9202032A ES2051643A1 ES 2051643 A1 ES2051643 A1 ES 2051643A1 ES 09202032 A ES09202032 A ES 09202032A ES 9202032 A ES9202032 A ES 9202032A ES 2051643 A1 ES2051643 A1 ES 2051643A1
Authority
ES
Spain
Prior art keywords
ubidecarenone
formulations
oral
aqueous solutions
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09202032A
Other languages
Spanish (es)
Other versions
ES2051643B1 (en
Inventor
Roberto Seghizzi
Giuseppe Furiosi
Ernesto Marco Martinelli
Giorgio Pifferi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDB Holding SpA
Original Assignee
IDB Holding SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDB Holding SpA filed Critical IDB Holding SpA
Priority to ES09202032A priority Critical patent/ES2051643B1/en
Publication of ES2051643A1 publication Critical patent/ES2051643A1/en
Application granted granted Critical
Publication of ES2051643B1 publication Critical patent/ES2051643B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceutical formulations, in the form of aqueous oral solutions, containing ubidecarenone as active ingredient, characterized in that they contain hydrogenated polyethoxylated castor oil 40, as a non-ionic surfactant.
ES09202032A 1992-10-13 1992-10-13 ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF AQUEOUS SOLUTIONS. Expired - Lifetime ES2051643B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES09202032A ES2051643B1 (en) 1992-10-13 1992-10-13 ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF AQUEOUS SOLUTIONS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09202032A ES2051643B1 (en) 1992-10-13 1992-10-13 ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF AQUEOUS SOLUTIONS.

Publications (2)

Publication Number Publication Date
ES2051643A1 true ES2051643A1 (en) 1994-06-16
ES2051643B1 ES2051643B1 (en) 1995-02-16

Family

ID=8278404

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09202032A Expired - Lifetime ES2051643B1 (en) 1992-10-13 1992-10-13 ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF AQUEOUS SOLUTIONS.

Country Status (1)

Country Link
ES (1) ES2051643B1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1334961A (en) * 1961-03-06 1963-08-16 Merck & Co Inc Stable aqueous solutions based on substituted benzoquinone
EP0083108A2 (en) * 1981-12-28 1983-07-06 Eisai Co., Ltd. Aqueous solution containing ubidecarenone
ES8600931A1 (en) * 1983-07-25 1985-10-16 Eisai Co Ltd Aqueous solution containing lipid-soluble pharmaceutical substance and a process for preparing the same.
GB2184355A (en) * 1985-12-24 1987-06-24 Seuref Ag Ubiquinone pharmaceutical compositions
EP0325244A1 (en) * 1988-01-22 1989-07-26 Eisai Co., Ltd. Aqueous solution of fat-soluble substance
EP0522433A1 (en) * 1991-07-11 1993-01-13 Inverni Della Beffa S.P.A. Oral aqueous solutions containing ubidecarenone

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1334961A (en) * 1961-03-06 1963-08-16 Merck & Co Inc Stable aqueous solutions based on substituted benzoquinone
EP0083108A2 (en) * 1981-12-28 1983-07-06 Eisai Co., Ltd. Aqueous solution containing ubidecarenone
ES8600931A1 (en) * 1983-07-25 1985-10-16 Eisai Co Ltd Aqueous solution containing lipid-soluble pharmaceutical substance and a process for preparing the same.
GB2184355A (en) * 1985-12-24 1987-06-24 Seuref Ag Ubiquinone pharmaceutical compositions
EP0325244A1 (en) * 1988-01-22 1989-07-26 Eisai Co., Ltd. Aqueous solution of fat-soluble substance
EP0522433A1 (en) * 1991-07-11 1993-01-13 Inverni Della Beffa S.P.A. Oral aqueous solutions containing ubidecarenone

Also Published As

Publication number Publication date
ES2051643B1 (en) 1995-02-16

Similar Documents

Publication Publication Date Title
FR2688422B1 (en)
CA2181172A1 (en) Storage-stable prostaglandin compositions
GR3023127T3 (en) Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3
FR2671800B1 (en) OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
EP0221732A3 (en) Sustained release tablets
TW355683B (en) Composition containing micronized nebivolol
MY118371A (en) Tetrahydrolipstatin containing compositions
IL106562A0 (en) Pharmaceutical and/or cosmetic compositions and the use thereof
TW280774B (en)
IT1263840B (en) ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
DK0437294T3 (en) Oral pharmaceutical preparations in unit dosage form
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
AU621763B2 (en) Stable tretinoin emulsified cream formulations
IT1250672B (en) ORAL FORMULATIONS OF UBIDECARENONE IN AQUEOUS SOLUTION
IL96903A0 (en) Topical pharmaceutical compositions comprising a vitamin d3 derivative
GB9525598D0 (en) Pharmaceutical tablet formulations
ES2051643A1 (en) Oral ubidecarenone formulations in the form of aqueous solutions
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
HUT61561A (en) Process for producing octadecyl-/2-(n-methylpiperidino)-ethyl/-phosphate and pharmaceutical compositions comprising same as active ingredient
GR1001364B (en) Ubidecarenone oral formulations in the form of aqueous solutions.
DE3261285D1 (en) Edible pharmaceutical form of a composition of matter containing a fluid dimethyl polysiloxane
HK1022278A1 (en) Pharmaceutical and cosmetic formulations with antimicrobial activity
WO1991013606A3 (en) Use of 3,7-dimethyloctan-1-ol in cosmetic and dermatological preparations
GB2161706B (en) New pharmaceutical and cosmetic compositions containing 10-acetyl-1,8,9-triacetoxyanthracene as active ingredient